April 2, 2019
Axcella Announces Patent Issuance for AXA™ Candidate AXA1125 Methods of Use
Patent issuance from Axcella’s broad Endogenous Metabolic Modulator (EMM) portfolio Claims cover methods of use of EMM compositions in liver…